Gainers
- Evaxion Biotech EVAX shares rose 92.1% to $4.61 during Tuesday's pre-market session. The company's market cap stands at $28.8 million.
- Anitra AZTR stock rose 55.15% to $0.43. The company's market cap stands at $5.3 million.
- Kairos Pharma KAPA shares moved upwards by 25.65% to $1.91. The market value of their outstanding shares is at $26.1 million.
- Achilles Therapeutics ACHL shares increased by 20.53% to $1.35. The market value of their outstanding shares is at $57.6 million.
- Invivyd IVVD shares rose 14.15% to $1.21. The company's market cap stands at $144.7 million.
- DBV Technologies DBVT stock increased by 13.3% to $4.6. The market value of their outstanding shares is at $94.3 million.
Losers
- Universe Pharmaceuticals UPC shares declined by 23.3% to $0.32 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.7 million.
- Foghorn Therapeutics FHTX stock decreased by 19.35% to $3.21. The market value of their outstanding shares is at $178.5 million.
- HCW Biologics HCWB stock fell 18.23% to $0.52. The company's market cap stands at $23.1 million.
- ImmuCell ICCC stock decreased by 12.36% to $4.4. The company's market cap stands at $39.2 million.
- Oruka Therapeutics ORKA stock declined by 12.34% to $12.01. The market value of their outstanding shares is at $420.3 million.
- Omega Therapeutics OMGA shares fell 12.34% to $0.42. The company's market cap stands at $23.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AZTRAzitra Inc
$0.376035.0%
DBVTDBV Technologies SA
$4.6314.0%
EVAXEvaxion Biotech AS
$4.3179.6%
FHTXFoghorn Therapeutics Inc
$3.21-19.4%
HCWBHCW Biologics Inc
$0.5201-18.2%
ICCCImmuCell Corp
$4.40-12.3%
IVVDInvivyd Inc
$1.2315.6%
KAPAKairos Pharma Ltd
$2.0132.2%
OMGAOmega Therapeutics Inc
$0.4278-10.7%
ORKAOruka Therapeutics Inc
$12.00-12.4%
UPCUniverse Pharmaceuticals Inc
$0.3100-25.7%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in